Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPension (IS)Property, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt issuances
Ratios

GE HealthCare Technologies (GEHC) EBIAT (2022 - 2025)

Historic EBIAT for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to $602.0 million.

  • GE HealthCare Technologies' EBIAT fell 1842.82% to $602.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.2 billion, marking a year-over-year increase of 502.19%. This contributed to the annual value of $2.2 billion for FY2025, which is 507.32% up from last year.
  • Latest data reveals that GE HealthCare Technologies reported EBIAT of $602.0 million as of Q4 2025, which was down 1842.82% from $464.0 million recorded in Q3 2025.
  • In the past 5 years, GE HealthCare Technologies' EBIAT registered a high of $738.0 million during Q4 2024, and its lowest value of $383.0 million during Q1 2023.
  • Moreover, its 4-year median value for EBIAT was $477.0 million (2024), whereas its average is $486.8 million.
  • Per our database at Business Quant, GE HealthCare Technologies' EBIAT plummeted by 2739.97% in 2023 and then skyrocketed by 7740.38% in 2024.
  • Quarter analysis of 4 years shows GE HealthCare Technologies' EBIAT stood at $573.0 million in 2022, then decreased by 27.4% to $416.0 million in 2023, then skyrocketed by 77.4% to $738.0 million in 2024, then decreased by 18.43% to $602.0 million in 2025.
  • Its EBIAT was $602.0 million in Q4 2025, compared to $464.0 million in Q3 2025 and $500.0 million in Q2 2025.